---
document_datetime: 2025-12-29 14:35:42
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/portrazza.html
document_name: portrazza.html
version: success
processing_time: 0.1060511
conversion_datetime: 2025-12-30 00:41:22.26221
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Portrazza

[RSS](/en/individual-human-medicine.xml/66041)

##### Withdrawn

This medicine's authorisation has been withdrawn

necitumumab Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Portrazza](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

The marketing authorisation for Portrazza (necitumumab) expired on 18 February 2021 following the decision of the marketing authorisation holder, Eli Lilly Nederland B.V., not to apply for a renewal of the marketing authorisation.

Eli Lilly Nederland B.V. confirmed that it did not apply for renewal of the authorisation due to the lack of demand for this product. Portrazza was granted marketing authorisation in the European Union (EU) on 15 February 2016 for the treatment of squamous non-small cell lung cancer.

The marketing authorisation was valid for a 5- year period. The marketing authorisation holder has committed to ensure that patients who benefit from Portrazza for the treatment of locally advanced or metastatic epidermal growth factor receptor (EGFR) expressing squamous non-small cell lung cancer can continue to receive treatment as appropriate.

The European Public Assessment Report (EPAR) for Portrazza is updated to indicate that the marketing authorisation is no longer valid.

Portrazza : EPAR - Summary for the public

Reference Number: EMA/14106/2016

English (EN) (661.27 KB - PDF)

**First published:** 04/03/2016

**Last updated:** 27/07/2021

[View](/en/documents/overview/portrazza-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-69)

български (BG) (746.85 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/bg/documents/overview/portrazza-epar-summary-public_bg.pdf)

español (ES) (659.55 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/es/documents/overview/portrazza-epar-summary-public_es.pdf)

čeština (CS) (736.21 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/cs/documents/overview/portrazza-epar-summary-public_cs.pdf)

dansk (DA) (658.42 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/da/documents/overview/portrazza-epar-summary-public_da.pdf)

Deutsch (DE) (662.7 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/de/documents/overview/portrazza-epar-summary-public_de.pdf)

eesti keel (ET) (657.54 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/et/documents/overview/portrazza-epar-summary-public_et.pdf)

ελληνικά (EL) (758.18 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/el/documents/overview/portrazza-epar-summary-public_el.pdf)

français (FR) (661.31 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/fr/documents/overview/portrazza-epar-summary-public_fr.pdf)

hrvatski (HR) (682.1 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/hr/documents/overview/portrazza-epar-summary-public_hr.pdf)

italiano (IT) (658.5 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/it/documents/overview/portrazza-epar-summary-public_it.pdf)

latviešu valoda (LV) (734.27 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/lv/documents/overview/portrazza-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (686.09 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/lt/documents/overview/portrazza-epar-summary-public_lt.pdf)

magyar (HU) (729.2 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/hu/documents/overview/portrazza-epar-summary-public_hu.pdf)

Malti (MT) (738.4 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/mt/documents/overview/portrazza-epar-summary-public_mt.pdf)

Nederlands (NL) (659.47 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/nl/documents/overview/portrazza-epar-summary-public_nl.pdf)

polski (PL) (734.44 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/pl/documents/overview/portrazza-epar-summary-public_pl.pdf)

português (PT) (660.7 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/pt/documents/overview/portrazza-epar-summary-public_pt.pdf)

română (RO) (685.29 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/ro/documents/overview/portrazza-epar-summary-public_ro.pdf)

slovenčina (SK) (735.06 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/sk/documents/overview/portrazza-epar-summary-public_sk.pdf)

slovenščina (SL) (726.15 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/sl/documents/overview/portrazza-epar-summary-public_sl.pdf)

Suomi (FI) (659.1 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/fi/documents/overview/portrazza-epar-summary-public_fi.pdf)

svenska (SV) (659.1 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/sv/documents/overview/portrazza-epar-summary-public_sv.pdf)

Portrazza : EPAR - Risk-management-plan summary

English (EN) (755.01 KB - PDF)

**First published:** 04/03/2016

**Last updated:** 27/07/2021

[View](/en/documents/rmp-summary/portrazza-epar-risk-management-plan-summary_en.pdf)

## Product information

Portrazza : EPAR - Product Information

English (EN) (1.09 MB - PDF)

**First published:** 04/03/2016

**Last updated:** 27/07/2021

[View](/en/documents/product-information/portrazza-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-791)

български (BG) (2.33 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/bg/documents/product-information/portrazza-epar-product-information_bg.pdf)

español (ES) (1.21 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/es/documents/product-information/portrazza-epar-product-information_es.pdf)

čeština (CS) (1.83 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/cs/documents/product-information/portrazza-epar-product-information_cs.pdf)

dansk (DA) (1.22 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/da/documents/product-information/portrazza-epar-product-information_da.pdf)

Deutsch (DE) (1.19 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/de/documents/product-information/portrazza-epar-product-information_de.pdf)

eesti keel (ET) (1.27 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/et/documents/product-information/portrazza-epar-product-information_et.pdf)

ελληνικά (EL) (2.15 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/el/documents/product-information/portrazza-epar-product-information_el.pdf)

français (FR) (1.25 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/fr/documents/product-information/portrazza-epar-product-information_fr.pdf)

hrvatski (HR) (1.32 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/hr/documents/product-information/portrazza-epar-product-information_hr.pdf)

íslenska (IS) (1.29 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/is/documents/product-information/portrazza-epar-product-information_is.pdf)

italiano (IT) (1.94 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/it/documents/product-information/portrazza-epar-product-information_it.pdf)

latviešu valoda (LV) (2.56 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/lv/documents/product-information/portrazza-epar-product-information_lv.pdf)

lietuvių kalba (LT) (2.12 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/lt/documents/product-information/portrazza-epar-product-information_lt.pdf)

magyar (HU) (1.81 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/hu/documents/product-information/portrazza-epar-product-information_hu.pdf)

Malti (MT) (1.86 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/mt/documents/product-information/portrazza-epar-product-information_mt.pdf)

Nederlands (NL) (1.17 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/nl/documents/product-information/portrazza-epar-product-information_nl.pdf)

norsk (NO) (1.23 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/no/documents/product-information/portrazza-epar-product-information_no.pdf)

polski (PL) (1.87 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/pl/documents/product-information/portrazza-epar-product-information_pl.pdf)

português (PT) (1.18 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/pt/documents/product-information/portrazza-epar-product-information_pt.pdf)

română (RO) (1.31 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/ro/documents/product-information/portrazza-epar-product-information_ro.pdf)

slovenčina (SK) (1.71 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/sk/documents/product-information/portrazza-epar-product-information_sk.pdf)

slovenščina (SL) (1.7 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/sl/documents/product-information/portrazza-epar-product-information_sl.pdf)

Suomi (FI) (1.48 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/fi/documents/product-information/portrazza-epar-product-information_fi.pdf)

svenska (SV) (1.14 MB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/sv/documents/product-information/portrazza-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** WITHDRAWAL 18/02/2021

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Portrazza : EPAR - All Authorised presentations

English (EN) (589.57 KB - PDF)

**First published:** 04/03/2016

**Last updated:** 27/07/2021

[View](/en/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-522)

български (BG) (632.95 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/bg/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_bg.pdf)

español (ES) (590.22 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/es/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_es.pdf)

čeština (CS) (613.19 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/cs/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (583.9 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/da/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (587.1 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/de/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (589.13 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/et/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (625.04 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/el/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_el.pdf)

français (FR) (586.92 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/fr/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (599.14 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/hr/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (582.38 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/is/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_is.pdf)

italiano (IT) (584.43 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/it/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (618.76 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/lv/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (602.19 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/lt/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (609.34 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/hu/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (613.8 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/mt/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (590.28 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/nl/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (590.13 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/no/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_no.pdf)

polski (PL) (622.18 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/pl/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_pl.pdf)

português (PT) (588.96 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/pt/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_pt.pdf)

română (RO) (605.29 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/ro/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (616.42 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/sk/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (606.7 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/sl/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (584.67 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/fi/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (583.91 KB - PDF)

**First published:**

04/03/2016

**Last updated:**

27/07/2021

[View](/sv/documents/all-authorised-presentations/portrazza-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Portrazza Active substance necitumumab International non-proprietary name (INN) or common name necitumumab Therapeutic area (MeSH) Carcinoma, Non-Small-Cell Lung Anatomical therapeutic chemical (ATC) code L01

### Pharmacotherapeutic group

Antineoplastic agents

### Therapeutic indication

Portrazza in combination with gemcitabine and cisplatin chemotherapy is indicated for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) expressing squamous non-small cell lung cancer who have not received prior chemotherapy for this condition.

## Authorisation details

EMA product number EMEA/H/C/003886 Marketing authorisation holder

Eli Lilly Nederland B.V.

Orteliuslaan 1000 3528 BD Utrecht Netherlands

Marketing authorisation issued 15/02/2016 Revision 3

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Portrazza : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (722.39 KB - PDF)

**First published:** 13/04/2016

**Last updated:** 27/07/2021

[View](/en/documents/procedural-steps-after/portrazza-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Portrazza : EPAR - Public assessment report

Adopted

Reference Number: EMA/CHMP/15391/2016

English (EN) (5.39 MB - PDF)

**First published:** 04/03/2016

**Last updated:** 27/07/2021

[View](/en/documents/assessment-report/portrazza-epar-public-assessment-report_en.pdf)

Summary of opinion for Portrazza

Adopted

Reference Number: EMA/CHMP/756429/2015

English (EN) (695.54 KB - PDF)

**First published:** 18/12/2015

**Last updated:** 27/07/2021

[View](/en/documents/smop-initial/summary-opinion-portrazza_en.pdf)

#### News on Portrazza

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 December 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-december-2015) 18/12/2015

**This page was last updated on** 27/07/2021

## Share this page

[Back to top](#main-content)